Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Pentaborate(1-) Salts and a Tetraborate(2-) Salt Derived from C2- or C3-Linked Bis(alkylammonium) Dications: Synthesis, Characterization, and Structural (XRD) Studies.

Beckett MA, Meena BI, Rixon TA, Coles SJ, Horton PN.

Molecules. 2019 Dec 23;25(1). pii: E53. doi: 10.3390/molecules25010053.

2.

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.

Skowron KB, Pitroda SP, Namm JP, Balogun O, Beckett MA, Zenner ML, Fayanju O, Huang X, Fernandez C, Zheng W, Qiao G, Chin R, Kron SJ, Khodarev NN, Posner MC, Steinberg GD, Weichselbaum RR.

Sci Rep. 2016 Oct 24;6:35854. doi: 10.1038/srep35854.

3.

Pentaborate(1-) salts templated by substituted pyrrolidinium cations: synthesis, structural characterization, and modelling of solid-state H-bond interactions by DFT calculations.

Beckett MA, Coles SJ, Davies RA, Horton PN, Jones CL.

Dalton Trans. 2015 Apr 21;44(15):7032-40. doi: 10.1039/c5dt00248f.

PMID:
25785672
4.

A new decaoxidooctaborate(2-) anion, [B8O10(OH)6](2-): synthesis and characterization of [Co(en)3][B5O6(OH)4][B8O10(OH)6)]·5H2O (en = 1,2-diaminoethane).

Altahan MA, Beckett MA, Coles SJ, Horton PN.

Inorg Chem. 2015 Jan 20;54(2):412-4. doi: 10.1021/ic5027834. Epub 2014 Dec 22.

PMID:
25531386
5.

Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing.

Liang H, Deng L, Chmura S, Burnette B, Liadis N, Darga T, Beckett MA, Lingen MW, Witt M, Weichselbaum RR, Fu YX.

J Immunol. 2013 Jun 1;190(11):5874-81. doi: 10.4049/jimmunol.1202612. Epub 2013 Apr 29.

6.

Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.

Pitroda SP, Zhou T, Sweis RF, Filippo M, Labay E, Beckett MA, Mauceri HJ, Liang H, Darga TE, Perakis S, Khan SA, Sutton HG, Zhang W, Khodarev NN, Garcia JG, Weichselbaum RR.

PLoS One. 2012;7(10):e46104. doi: 10.1371/journal.pone.0046104. Epub 2012 Oct 4.

7.

Templated heptaborate and pentaborate salts of cyclo-alkylammonium cations: structural and thermal properties.

Beckett MA, Horton PN, Hursthouse MB, Timmis JL, Varma KS.

Dalton Trans. 2012 Apr 21;41(15):4396-403. doi: 10.1039/c2dt12310j. Epub 2012 Feb 17.

PMID:
22344458
8.
9.

Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymers.

Soneru AP, Beckett MA, Weichselbaum RR, Lee RC.

Health Phys. 2011 Dec;101(6):731-8. doi: 10.1097/HP.0b013e3182166759.

10.

Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.

Barreto-Andrade JC, Efimova EV, Mauceri HJ, Beckett MA, Sutton HG, Darga TE, Vokes EE, Posner MC, Kron SJ, Weichselbaum RR.

Mol Cancer Ther. 2011 Jul;10(7):1185-93. doi: 10.1158/1535-7163.MCT-11-0061. Epub 2011 May 13.

11.

Structural (XRD) and thermal (DSC, TGA) and BET analysis of materials derived from non-metal cation pentaborate salts.

Beckett MA, Horton PN, Hursthouse MB, Knox DA, Timmis JL.

Dalton Trans. 2010 Apr 28;39(16):3944-51. doi: 10.1039/b927072h. Epub 2010 Mar 11.

PMID:
20372719
12.

Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cells.

Meng Y, Mauceri HJ, Khodarev NN, Darga TE, Pitroda SP, Beckett MA, Kufe DW, Weichselbaum RR.

Mol Ther. 2010 May;18(5):912-20. doi: 10.1038/mt.2010.18. Epub 2010 Mar 2.

13.

Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.

Meng Y, Beckett MA, Liang H, Mauceri HJ, van Rooijen N, Cohen KS, Weichselbaum RR.

Cancer Res. 2010 Feb 15;70(4):1534-43. doi: 10.1158/0008-5472.CAN-09-2995. Epub 2010 Feb 9.

14.

Tetra-phenyl-phospho-nium octa-hydro-triborate.

Beckett MA, Horton PN, Hursthouse MB, Pszolla C.

Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 13;66(Pt 4):o833. doi: 10.1107/S1600536810008263.

15.

Bis(triphenyl-phospho-ranyl-idene)ammonium iodide.

Beckett MA, Horton PN, Hursthouse MB, Timmis JL.

Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 9;66(Pt 2):o319. doi: 10.1107/S1600536810000267.

16.

STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect.

Pitroda SP, Wakim BT, Sood RF, Beveridge MG, Beckett MA, MacDermed DM, Weichselbaum RR, Khodarev NN.

BMC Med. 2009 Nov 5;7:68. doi: 10.1186/1741-7015-7-68.

17.

STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.

Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, Darga TE, Beveridge MG, Sood RF, Sutton HG, Beckett MA, Mauceri HJ, Posner MC, Weichselbaum RR.

PLoS One. 2009 Jun 8;4(6):e5821. doi: 10.1371/journal.pone.0005821.

18.

MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.

Khodarev NN, Pitroda SP, Beckett MA, MacDermed DM, Huang L, Kufe DW, Weichselbaum RR.

Cancer Res. 2009 Apr 1;69(7):2833-7. doi: 10.1158/0008-5472.CAN-08-4513. Epub 2009 Mar 24.

19.

MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.

Pitroda SP, Khodarev NN, Beckett MA, Kufe DW, Weichselbaum RR.

Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5837-41. doi: 10.1073/pnas.0812029106. Epub 2009 Mar 16.

20.

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.

Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR.

Cancer Gene Ther. 2009 Apr;16(4):373-81. doi: 10.1038/cgt.2008.86. Epub 2008 Oct 31.

21.

Synthesis of aluminium borate-boron oxide and binary titanium-boron and zirconium-boron oxides from metal alkoxides and (MeO)3B3O3 in non-aqueous solvents.

Beckett MA, Rugen-Hankey MP, Timmis JL, Varma KS.

Dalton Trans. 2008 Mar 21;(11):1503-6. doi: 10.1039/b717379b. Epub 2008 Feb 12.

PMID:
18322631
22.

An unprecedented polyborate ester anion: X-ray diffraction studies on [1,8-C10H6(NMe2)2H][B5O6(OMe)4].

Beckett MA, Bland CC, Horton PN, Hursthouse MB, Varma KS.

Inorg Chem. 2007 May 14;46(10):3801-3. Epub 2007 Apr 10.

PMID:
17419620
23.

Establishment of a syngeneic model of hepatic colorectal oligometastases.

Mezhir JJ, Smith KD, Kimchi ET, Park JO, Lopez CA, Mauceri HJ, Beckett MA, Hellman S, Weichselbaum RR, Posner MC.

J Surg Res. 2006 Dec;136(2):288-93. Epub 2006 Aug 23.

PMID:
16930623
24.

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.

Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ.

Cancer Chemother Pharmacol. 2005 Sep;56(3):317-21. Epub 2005 May 11.

PMID:
15887016
25.

Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.

Lopez CA, Kimchi ET, Mauceri HJ, Park JO, Mehta N, Murphy KT, Beckett MA, Hellman S, Posner MC, Kufe DW, Weichselbaum RR.

Mol Cancer Ther. 2004 Sep;3(9):1167-75.

26.

Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation.

Greenebaum B, Blossfield K, Hannig J, Carrillo CS, Beckett MA, Weichselbaum RR, Lee RC.

Burns. 2004 Sep;30(6):539-47.

PMID:
15302418
27.

Iron release from corroded iron pipes in drinking water distribution systems: effect of dissolved oxygen.

Sarin P, Snoeyink VL, Bebee J, Jim KK, Beckett MA, Kriven WM, Clement JA.

Water Res. 2004 Mar;38(5):1259-69.

PMID:
14975659
28.

Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).

Lopez CA, Park JO, Mauceri HJ, Beckett MA, Weichselbaum RR, Posner MC.

Int J Oncol. 2004 Mar;24(3):731-6. Review.

PMID:
14767560
29.

Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.

Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ, Weichselbaum RR.

J Biol Chem. 2004 Jan 16;279(3):2273-80. Epub 2003 Oct 15.

30.

Enhanced sonochemical decomposition of 1,4-dioxane by ferrous iron.

Beckett MA, Hua I.

Water Res. 2003 May;37(10):2372-6.

PMID:
12727247
31.

Angiostatin potentiates cyclophosphamide treatment of metastatic disease.

Mauceri HJ, Seetharam S, Beckett MA, Schumm LP, Koons A, Gupta VK, Park JO, Manan A, Lee JY, Montag AG, Kufe DW, Weichselbaum RR.

Cancer Chemother Pharmacol. 2002 Nov;50(5):412-8. Epub 2002 Sep 18.

PMID:
12439600
32.

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.

Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR.

Cancer J. 2002 Jan-Feb;8(1):47-54.

PMID:
11895203
33.

Tumor production of angiostatin is enhanced after exposure to TNF-alpha.

Mauceri HJ, Seetharam S, Beckett MA, Lee JY, Gupta VK, Gately S, Stack MS, Brown CK, Swedberg K, Kufe DW, Weichselbaum RR.

Int J Cancer. 2002 Feb 1;97(4):410-5.

34.

Angiostatin effects on endothelial cells mediated by ceramide and RhoA.

Gupta N, Nodzenski E, Khodarev NN, Yu J, Khorasani L, Beckett MA, Kufe DW, Weichselbaum RR.

EMBO Rep. 2001 Jun;2(6):536-40.

35.

NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.

Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR.

Cancer Res. 2000 Dec 15;60(24):6958-63.

36.

Antitumor interaction of short-course endostatin and ionizing radiation.

Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.

Cancer J. 2000 Sep-Oct;6(5):287-93.

PMID:
11079167
37.

Angiostatin induces mitotic cell death of proliferating endothelial cells.

Hari D, Beckett MA, Sukhatme VP, Dhanabal M, Nodzenski E, Lu H, Mauceri HJ, Kufe DW, Weichselbaum RR.

Mol Cell Biol Res Commun. 2000 May;3(5):277-82.

PMID:
10964751
38.

Surfactant sealing of membranes permeabilized by ionizing radiation.

Hannig J, Zhang D, Canaday DJ, Beckett MA, Astumian RD, Weichselbaum RR, Lee RC.

Radiat Res. 2000 Aug;154(2):171-7.

PMID:
10931689
39.

Oxidative cell membrane alteration. Evidence for surfactant-mediated sealing.

Terry MA, Hannig J, Carrillo CS, Beckett MA, Weichselbaum RR, Lee RC.

Ann N Y Acad Sci. 1999 Oct 30;888:274-84.

PMID:
10842639
40.

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR.

Cancer Res. 1999 Jul 15;59(14):3374-8.

41.

Radiation-inducible gene therapy.

Mauceri HJ, Hanna NN, Staba MJ, Beckett MA, Kufe DW, Weichselbaum RR.

C R Acad Sci III. 1999 Feb-Mar;322(2-3):225-8. Review.

PMID:
10196676
42.

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW, Weichselbaum RR.

Cancer Res. 1998 Dec 15;58(24):5686-9.

43.

Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.

Seetharam S, Nodzenski E, Beckett MA, Heimann R, Cha A, Margulies I, Pastan I, Kufe DW, Weichselbaum RR.

Cancer Res. 1998 Aug 1;58(15):3215-20.

44.

Combined effects of angiostatin and ionizing radiation in antitumour therapy.

Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW, Weichselbaum RR.

Nature. 1998 Jul 16;394(6690):287-91.

PMID:
9685160
45.

Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.

Chmura SJ, Mauceri HJ, Advani S, Heimann R, Beckett MA, Nodzenski E, Quintans J, Kufe DW, Weichselbaum RR.

Cancer Res. 1997 Oct 1;57(19):4340-7.

46.

Loss of ceramide production confers resistance to radiation-induced apoptosis.

Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR.

Cancer Res. 1997 Apr 1;57(7):1270-5.

47.

DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.

Schwartz JL, Mustafi R, Beckett MA, Weichselbaum RR.

Br J Cancer. 1996 Jul;74(1):37-42.

48.

Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.

Seung LP, Mauceri HJ, Beckett MA, Hallahan DE, Hellman S, Weichselbaum RR.

Cancer Res. 1995 Dec 1;55(23):5561-5.

49.

Clonal interactions in a human squamous cell carcinoma.

Spellman JE Jr, Kulesz-Martin MF, Blumenson LE, Beckett MA, Weichselbaum RR.

J Surg Res. 1995 Feb;58(2):165-74.

PMID:
7861768
50.

Cellular and molecular mechanisms of radioresistance.

Weichselbaum RR, Beckett MA, Vokes EE, Brachman DG, Haraf D, Hallahan D, Kufe D.

Cancer Treat Res. 1995;74:131-40. Review. No abstract available.

PMID:
7779612

Supplemental Content

Loading ...
Support Center